Atlas Trials

Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta

Clinical trial NCT03064074 · COMPLETED

Trial details

NCT number
NCT03064074
Sponsor
Baylor College of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Osteogenesis Imperfecta
Start date
2017-11-15
Primary completion
2022-07-04
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.